Child dies in Capsida study of rare disease gene therapy

Capsida is investigating the root cause of the death, which occurred in the first patient treated in a trial of the company’s therapy for a rare neurodevelopmental disorder.

LB Pharmaceuticals raises $285M in first major biotech IPO since February

LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for large IPOs in years.

Driving precision oncology development: Integrated biomarker testing solutions that deliver impact

Biotech IPOs are the industry’s lifeblood. Track how they’re performing.

LB Pharmaceuticals’ $285 million offering is the first sizable IPO since February and the largest for a biotech company this year, according to BioPharma Dive data.

FDA shares guidance to drugmakers developing non-opioid pain medicines

The agency says it’s open to offering speedy approval pathways for new pain medications that can fight the ongoing opioid addiction crisis.

Novo Nordisk to lay off 9,000 workers in major restructuring

The drugmaker’s new CEO said the moves will help the company be more agile as it deals with competition in the obesity market and a declining stock price.